Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04143516 · ClinicalTrials.gov registry record · Phase 2
Tissue Analysis After Tumor Ablation for Liver Metastases Leading to Immediate Retreatment
A Phase 2 study of Liver Metastases, sponsored by Memorial Sloan Kettering Cancer Center.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT04143516: Recruiting Phase 2 study of Liver Metastases, sponsored by Memorial Sloan Kettering Cancer Center.
NCT04143516 is a Phase 2 study of Liver Metastases that is actively recruiting participants, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 200 participants, above the 61-participant average among 27 other Liver Metastases trials with a reported enrollment target (228% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04143516, a Phase 2 study of Liver Metastases, is actively recruiting participants, sponsored by Memorial Sloan Kettering Cancer Center.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will see whether collecting and analyzing needle biopsy samples from cancer liver metastases after a tumor ablation procedure will be able to identify cancer cells that are still alive. The results of these biopsies could help determine the next treatment for your cancer, but the biopsies could cause side effects.
Primary Outcome
will be measured according to RECIST and PERCIST 1.0. The first CT and PET scan taken after ablation will be considered the new baseline for subsequent comparisons and measurements.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST PET/CT Scan
- DIAGNOSTIC_TEST [18-F]- FDG - PET
- PROCEDURE Tumor ablation (TA)
Study Locations (1)
New York
- Memorial Sloan Kettering Cancer Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2019-10-25 |
| Est. Completion | 2026-10 |
| Phase | Phase 2 |
What NCT04143516 shows while recruiting
NCT04143516 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, above the 61-participant average among 27 other Liver Metastases trials with a reported enrollment target (228% higher).
The record links to 1 condition, with Liver Metastases appearing as the primary indexed condition, and to 3 interventions - of which PET/CT Scan is the first listed.
NCT04143516 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT04143516 about?
NCT04143516 is a clinical study titled "Tissue Analysis After Tumor Ablation for Liver Metastases Leading to Immediate Retreatment". This study will see whether collecting and analyzing needle biopsy samples from cancer liver metastases after a tumor ablation procedure will be able to identify cancer cells that are still alive. The results of these biopsies could help determine the next treatment for your cancer, but the biopsies...
What is the current status of trial NCT04143516?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 200 participants. The study started on 2019-10-25. Estimated completion is 2026-10.
What conditions does trial NCT04143516 study?
This clinical trial studies the following conditions: Liver Metastases.
What interventions are being tested in trial NCT04143516?
The interventions under investigation include: PET/CT Scan (DIAGNOSTIC_TEST), [18-F]- FDG - PET (DIAGNOSTIC_TEST), Tumor ablation (TA) (PROCEDURE).
Who is sponsoring clinical trial NCT04143516?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04143516 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Liver Metastases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04143516's enrollment target sits among peer trials
200 3rd of 27 higher than 25 of 27 other Liver Metastases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Liver Metastases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study of Single Fraction Stereotactic Body Radiation Therapy (SBRT) Guided by Magnetic Resonance Imaging (MRI) in People With Liver Metastasis From Colorectal Cancer
RECRUITING · Phase 2
-
REGULUS: MRI-guided Adaptive SABR for Liver Cancers
RECRUITING · Phase 2
-
Study of Bevacizumab in Combination With Chemoimmunotherapy and Atezolizumab in Patients With Extensive Stage Small Cell Lung Cancer and Liver Metastases
RECRUITING · Phase 2
-
Platform Study of Immunotherapy Combinations in Colorectal Cancer Liver Metastases
RECRUITING · Phase 2
-
ctDNA-Directed Post-Hepatectomy Chemotherapy for Patients With Resectable Colorectal Liver Metastases
RECRUITING · Phase 2
-
Hepatic Artery Infusional Floxuridine to Treat Pancreatic Cancer Liver Metastases
ACTIVE NOT RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI